Back to homeMedixaRequest Access

Medixa Peptides

Physician-dispensed peptide protocols personalized for each patient.

Metabolic & Weight ManagementSemaglutide
Semaglutide icon

Semaglutide

2.5 mg vial

Obesity, metabolic syndrome, insulin resistance, type 2 diabetes

An FDA-approved GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin sensitivity. Proven 15-17% body weight reduction in clinical trials.

FDA-approved with strongest weight-loss evidence base

$299.95suggested retail

More peptides coming soon — 120+ in our knowledge base

Ready to offer these protocols to your patients?

Set up your branded storefront in under 5 minutes. Our AI handles patient outreach, protocol matching, renewals, and support.

See it in action